TickerFacts.

Boston Scientific Corp (BSX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$4.98B
Year ended 2025-12-31
$5.57B
Trailing 12 months to 2026-06-30
+21.4%
3-year compound annual growth
+36.7%
5-year compound annual growth
+26.2%
10-year compound annual growth
2007-12-31: $904.00M2008-12-31: -$641.00M2009-12-31: -$60.00M2010-12-31: $160.00M2011-12-31: $1.62B2012-12-31: -$3.19B2013-12-31: $809.00M2014-12-31: $424.00M2015-12-31: $486.00M2016-12-31: $1.26B2017-12-31: $2.13B2018-12-31: $2.40B2019-12-31: $2.53B2020-12-31: $1.04B2021-12-31: $2.29B2022-12-31: $2.79B2023-12-31: $3.54B2024-12-31: $3.87B2025-12-31: $4.98B$4.98B
2007-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$4.98B+28.6%2026-02-17, From 2025-01-01
2024-12-31$3.87B+9.4%2026-02-17, From 2024-01-01
2023-12-31$3.54B+27.1%2026-02-17, From 2023-01-01
2022-12-31$2.79B+21.5%2025-02-18, From 2022-01-01
2021-12-31$2.29B+119.8%2024-02-20, From 2021-01-01
2020-12-31$1.04B-58.8%2023-02-23, From 2020-01-01
2019-12-31$2.53B+5.4%2022-02-23, From 2019-01-01
2018-12-31$2.40B+12.7%2021-02-23, From 2018-01-01
2017-12-31$2.13B+68.7%2020-02-25, From 2017-01-01
2016-12-31$1.26B+159.7%2019-02-19, From 2016-01-01
2015-12-31$486.00Mn/c2018-02-20, From 2015-01-01
2014-12-31$424.00M-47.6%2017-02-23, From 2014-01-01
2013-12-31$809.00Mn/m2016-02-24, From 2013-01-01
2012-12-31-$3.19Bn/m2015-02-25, From 2012-01-01
2011-12-31$1.62B+913.1%2014-02-26, From 2011-01-01
2010-12-31$160.00Mn/m2013-02-22, From 2010-01-01
2009-12-31-$60.00Mn/m2012-02-17, From 2009-01-01
2008-12-31-$641.00Mn/m2011-02-17, From 2008-01-01
2007-12-31$904.00Mn/a2010-02-26, From 2007-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Boston Scientific Corp (BSX)2025-12-31$4.98B+28.6%
Becton Dickinson & Co (BDX)2025-09-30$5.04B+7.6%
3M Co (MMM)2025-12-31$5.94B-4.0%
Stryker Corp (SYK)2025-12-31$6.46B+26.3%
Medline Inc. (MDLN)2025-12-31$3.22B+3.2%
Baxter International Inc (BAX)2025-12-31$673.00M-33.4%
Solventum Corp (SOLV)2025-12-31$2.67B+67.8%
ResMed Inc (RMD)2026-06-30$2.09B+10.8%
Dexcom Inc (DXCM)2025-12-31$1.16B+42.3%

Compare BSX, BDX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗